Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands

被引:30
作者
Van Boxel, O. S. [1 ]
Hagenaars, M. P. [2 ]
Smout, A. J. P. M. [1 ]
Siersema, P. D. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, NL-3584 CX Utrecht, Netherlands
[2] Achmea Hlth Insurance, Leiden, Netherlands
关键词
GASTROESOPHAGEAL-REFLUX DISEASE; PREVALENCE; GUIDELINES; SYMPTOMS; ARTICLE; DUTCH; RISK;
D O I
10.1111/j.1365-2036.2008.03900.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chronic proton pump inhibitor (PPI) use is common in the Western world. Socio-economic status and socio-demographic factors have been shown to influence decisions related to prescribing of various drugs, but the influence of these factors on chronic PPI use is uncertain. To study the influence of SES and socio-demographic factors on chronic PPI use. Data were collected from a database of a Dutch health insurance company. Subjects having had at least one prescription for a PPI were identified and followed up for 6 months. Patients were then subdivided into chronic PPI users. Socio-demographic status was based on neighbourhood level of residence. Logistic regression was performed to determine socio-demographic factors associated with PPI use. A total of 2 001 787 insured individuals were included, 85 253 subjects were chronic users. Both low income (OR 1.55; CI 1.52-1.58) and low educational level (OR 1.33; CI 1.31-1.36) were associated with chronic PPI use. Other independent predictive variables included use of 10 or more concomitant medications (OR 5.33; CI 4.96-5.72) and the use of prokinetic drugs (OR 10.01; CI 9.22-10.88). Patients of a lower socio-demographic status are more likely to use PPIs on a chronic basis. The observed gradient in PPIs use may reflect differences in health, healthcare use or healthcare supply.
引用
收藏
页码:571 / 579
页数:9
相关论文
共 28 条
  • [1] Long-term persistence in use of statin therapy in elderly patients
    Benner, JS
    Glynn, RJ
    Mogun, H
    Neumann, PJ
    Weinstein, MC
    Avorn, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (04): : 455 - 461
  • [2] Treatment of heart failure in Dutch general practice
    Bongers F.J.M.
    Schellevis F.G.
    Bakx C.
    Van Den Bosch W.J.H.M.
    Van Der Zee J.
    [J]. BMC Family Practice, 7 (1)
  • [3] Effectiveness of Proton Pump Inhibitors in Nonerosive Reflux Disease
    Dean, Bonnie B.
    Gano, Anacleto D., Jr.
    Knight, Kevin
    Ofman, Joshua J.
    Fass, Ronnie
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (08) : 656 - 664
  • [4] Updated guidelines for the diagnosis and treatment of Gastroesophageal reflux disease
    DeVault, KR
    Castell, DO
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (01) : 190 - 200
  • [5] Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease
    Dial, S
    Delaney, JAC
    Barkun, AN
    Suissa, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (23): : 2989 - 2995
  • [6] PATTERN OF DRUG-USE IN A GENERAL-POPULATION PREVALENCE AND PREDICTING FACTORS - THE TROMSO STUDY
    EGGEN, AE
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1994, 23 (06) : 1262 - 1272
  • [7] Going dutch - Managed-competition health insurance in the Netherlands
    Enthoven, Alain C.
    van de Ven, Wynand P. M. M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (24) : 2421 - 2423
  • [8] Relation between gastroesophageal reflux symptoms and socioeconomic factors: A population-based study (the HUNT study)
    Jansson, Catarina
    Nordenstedt, Helena
    Johansson, Saga
    Wallander, Mari-Ann
    Johnsen, Roar
    Hveem, Kristian
    Lagergren, Jesper
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (09) : 1029 - 1034
  • [9] Dutch doctors and their patients - Effects of health care reform in the Netherlands
    Knottnerus, J. Andre
    ten Velden, Gabriel H. M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (24) : 2424 - 2426
  • [10] Koloski NA, 2002, AM J GASTROENTEROL, V97, P2290